Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Mini Review ABCC1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) Franck Viguié Laboratoire de Cytogénétique - Service d'Hématologie Biologique, Hôpital Hôtel-Dieu, 75181 Paris Cedex 04, France (FV) Published in Atlas Database: November 1998 Online updated version : http://AtlasGeneticsOncology.org/Genes/MRPID106.html DOI: 10.4267/2042/37476 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 1999 Atlas of Genetics and Cytogenetics in Oncology and Haematology Localisation Identity Other names: MRP associated protein) HGNC (Hugo): ABCC1 Location: 16p13.1 Note: MRP is a gene resistance, discovered in glycoprotein negative, carcinoma cell line. (multidrug In normal cells, predominant localisation in the cytoplasm; in tumor cells, predominant in plasma membrane, but also found in endoplasmic reticulum, indicating a probable different function as in normal cells. resistance- Function involved in multidrug a multidrug-resistant, Pnon small cell lung Plasma membrane drug-efflux pump; MRP induces a multidrug resistance phenotype (MDR phenotype); overexpression confers tumor cell resistance to a wide variety of hydrophobic drugs: doxorubicin, daunorubicin, vinblastine, vincristine, colchicine, VP16, Rhodamin 123; glutathione is required for the effective expulsion of the chemotherapeutic agents; the mode of action of MRP is very similar to the one of P-glycoprotein, the main protein responsible for the MDR phenotype; however, MRP does not confer resistance to Taxol or m-AMSA, but it is able to transport metallic oxyanions, glutathione and other glutathione conjugates; inhibitors of organic anion transport, such as probenecid, can block MRP activity. DNA/RNA Description Spans at least 200 kb and contains 31 exons Transcription 7 kb mRNA transcript; significant level of variant transcripts due to alternative splicing. Protein Description 1531 amino acids, 190 kDa; contains two ATP binding domains and three membrane-spanning helices; member of the ATP-binding cassette proteins (ABC proteins). Homology Structural and/or functional homology with other ABC transporter proteins (CFTR, Pgp, MOAT). Expression Implicated in Expressed at a basal level in a wide variety of normal tissues, including epithelial cells and all hematopoietic cell types, which suggests a function common to most cell types; increased expression in various tumor cell type. Atlas Genet Cytogenet Oncol Haematol. 1999; 3(1) Induced resistance to chemotherapeutic agents 11 ABCC1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia. 1994 Jun;8(6):990-7 Disease In a wide variety of solid and hematological tumors. Oncogenesis MRP hyperexpression may confer therapeutic resistance in leukemia and solid tumor; however its relative importance, in comparison with other proteins able to induce the MDR phenotype (P-gp, LRP), is not yet clear; hyperexpression is probably linked to transcriptional activation of the gene and/or increased mRNA stability, and not to gene amplification; increased expression of MRP mRNA and protein is a factor of bad prognostic in neuroblastoma, retinoblastoma, and non small cell lung carcinoma. In haematological malignancies, overexpression is frequent in chronic lymphocytic leukemia and prolymphocytic leukemia, occasional in acute myeloid leukemia and rare in acute lymphoid leukemia, lymphoma, multiple myeloma and myeloproliferative disorders. Zaman GJ, Flens MJ, van Leusden MR, de Haas M, Mülder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ. The human multidrug resistanceassociated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8822-6 Barrand MA, Bagrij T, Neo SY. Multidrug resistanceassociated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion. Gen Pharmacol. 1997 May;28(5):639-45 Deeley RG, Cole SP. Function, evolution and structure of multidrug resistance protein (MRP). Semin Cancer Biol. 1997 Jun;8(3):193-204 Kavallaris M. The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance. Anticancer Drugs. 1997 Jan;8(1):17-25 Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol. 1997;40 Suppl:S3-8 Willman CL. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program. Semin Hematol. 1997 Oct;34(4 Suppl 5):25-33 References Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. Overexpression of a transporter gene in a multidrugresistant human lung cancer cell line. Science. 1992 Dec 4;258(5088):1650-4 This article should be referenced as such: Viguié F. ABCC1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1). Atlas Genet Cytogenet Oncol Haematol. 1999; 3(1):11-12. Burger H, Nooter K, Zaman GJ, Sonneveld P, van Wingerden KE, Oostrum RG, Stoter G. Expression of the Atlas Genet Cytogenet Oncol Haematol. 1999; 3(1) Viguié F 12